Growth Capital Firm Profile
Montreux Equity Partners’ most common sectors for investment aremedical products (45%) and life science (30%) . The Firm’s most common investment types include venture (75%) and buyout (lbo, mbo, mbi) (12%). In total, Montreux Equity Partners has invested in 5 US states and 3 different countries. Its largest (disclosed) acquisition occurred in 2006 when it acquired OREXIGEN Therapeutics for $30M.
In the last 3 years, Montreux Equity Partners has exited 1 company. The Firm’s most common exit type is trade sale (63%). Montreux Equity Partners’ largest (disclosed) exit occurred in 2007 when it sold Cerexa for $480M.
Join Mergr to view Montreux Equity Partners’ full profile and discover more small growth capital firm investors just like it.
M&A Summary
-
M&A Total Activity51
- M&A Buy Activity27
- M&A Sell Activity24
- Total Sectors Invested 7
- Total Countries Invested 3
- M&A Buy/Sell Connections 25
- M&A Advisors 1
Unlimited Searches
